The Impact of Hispanic Ethnicity and the Titration Effect of LY2189265, a Glucagon-Like Peptide 1 Analog, on Metabolic Outcome Measures in Patients with Uncontrolled Type 2 Diabetes Mellitus (T2DM): An EGO Study Analysis.

被引：0
|
作者：
Bastyr, E. J., III [1 ,2 ]
Cheng, C. L. [1 ]
Noriega, J. E. [1 ,2 ]
Thompson, A. B. [1 ]
Threlkeld, R. J. [1 ]
Shu, J. [3 ]
Glass, L. C. [1 ]
机构：
[1] Lilly Res Labs, Indianapolis, IN USA
[2] Indiana Univ, Sch Med, Indianapolis, IN USA
[3] i3 Statprobe, Ann Arbor, MI USA
来源：
ENDOCRINE REVIEWS | 2010年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] TTP054, a Novel, Orally-Available Glucagon-like Peptide-1 (GLP-1) Agonist, Lowers HbA1c in Subjects with Type 2 Diabetes Mellitus (T2DM)
    Gustavson, Stephanie
    Grimes, Imogene
    Valcarce, Carmen
    Burstein, Aaron
    Mjalli, Adnan
    DIABETES, 2014, 63 : A41 - A42
  • [32] The effect of Glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in type 2 diabetes mellitus patients with coronary artery disease
    Tjerkaski, J.
    Matthews, A.
    Alfredsson, J.
    Erlinge, D.
    Hofmann, R.
    Svensson, P.
    Lindahl, B.
    Mohammad, M. A.
    Omerovic, E.
    Reitan, C.
    Jernberg, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [33] The effect of Glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in type 2 diabetes mellitus patients with coronary artery disease
    Tjerkaski, J.
    Matthews, A.
    Alfredsson, J.
    Erlinge, D.
    Hofmann, R.
    Svensson, P.
    Lindahl, B.
    Mohammad, M. A.
    Omerovic, E.
    Reitan, C.
    Jernberg, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [34] Effect of glucagon-like peptide-1 on major cardiovascular outcomes in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
    Ding, Song
    Du, Yong-ping
    Lin, Nan
    Su, Yuan-yuan
    Yang, Fan
    Kong, Ling-cong
    Ge, Heng
    Pu, Jun
    He, Ben
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 : 957 - 962
  • [35] Retrospective Study of Adherence to Glucagon-like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes Mellitus in the United States
    Stephen S. Johnston
    Hiep Nguyen
    Eugene Felber
    Katherine Cappell
    James K. Nelson
    Bong-Chul Chu
    Iftekhar Kalsekar
    Advances in Therapy, 2014, 31 : 1119 - 1133
  • [36] Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study
    Federici, Marco Orsini
    McQuillan, Janette
    Biricolti, Giovanni
    Losi, Serena
    Lebrec, Jeremie
    Richards, Catrina
    Miglio, Cristiana
    Norrbacka, Kirsi
    DIABETES THERAPY, 2018, 9 (02) : 789 - 801
  • [37] Retrospective Study of Adherence to Glucagon-like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes Mellitus in the United States
    Johnston, Stephen S.
    Hiep Nguyen
    Felber, Eugene
    Cappell, Katherine
    Nelson, James K.
    Chu, Bong-Chul
    Kalsekar, Iftekhar
    ADVANCES IN THERAPY, 2014, 31 (11) : 1119 - 1133
  • [38] Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study
    Marco Orsini Federici
    Janette McQuillan
    Giovanni Biricolti
    Serena Losi
    Jeremie Lebrec
    Catrina Richards
    Cristiana Miglio
    Kirsi Norrbacka
    Diabetes Therapy, 2018, 9 : 789 - 801
  • [39] Utilization patterns of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus in Germany: a retrospective cohort study
    Otto, Thorsten
    Myland, Melissa
    Jung, Heike
    Lebrec, Jeremie
    Richter, Hartmut
    Norrbacka, Kirsi
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (05) : 893 - 901
  • [40] Real-World Comparative Effectiveness, Treatment Patterns, and Costs in Type 2 Diabetes Mellitus (T2DM) Patients Initiated on Canagliflozin 300 mg (CANA) or a Glucagon-Like Peptide-1 Receptor Agonist (GLP-1)
    Singhal, Mukul
    Tan, Hiangkiat
    Coleman, Craig I.
    Herman, William H.
    Cai, Jennifer
    Han, Michelle
    Ingham, Mike
    DIABETES, 2018, 67
12345